newsfilter
← Latest News
Business Wire·

United Therapeutics Corporation Announces FDA Clearance to Proceed with UHeart Xenotransplantation Clinical Trial

First-ever human clinical trial of a xenoheart intended to support potential registration through the submission of a Biologics License Application to the U.S. FDA United Therapeutics Corporation (NASDAQ:UTHR), a